A team of researchers at the North West Embryonic Stem Cell Centre, Manchester, has revealed after its latest study that embryo stem cells play a major role in treating and improving the eyesight of patients who are officially supposed to be blind.

It has been found by the recent report that millions are hoped to get their conditions improved with the international trial offer. The trial is being conducted in order to test whether or not the operation is safe. Thus, it has been decided by the trial organizers that they would conduct the trial on those people who are blind and severely far or near sighted.

According to the findings by the reporters, the treatment includes injection of the stem cells into the eye of patients so as to replace the damaged cells in the retina i. e. the light-sensitive layer at the back of the eye. It is being said that the treatment has already been given to a patient in Europe, who was injected with stem cells. He has been known to have successfully developed healthy versions of damaged retinal cells.

The report finds that the trial is being taken with an aim to check if operation would be successful and it would include patients who have left the hope of getting their vision restored or improved. However, the treatment could take years to be available on the NHS but it has already been welcomed by the experts as it is believed to be a total life changing treatment.

"This is the first peer-reviewed scientific report showing cells derived from human embryonic stem cells can be transplanted safely into a patient with no sign of complications", said Professor Daniel Brison, from the North West Embryonic Stem Cell Centre, Manchester.